Mario Gabelli Ligand Pharmaceuticals Inc Put Options Transaction History
Gamco Investors, Inc. Et Al
- $9.22 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
234Shares Held
16.5MCall Options Held
77.9KPut Options Held
25K-
Black Rock Inc. New York, NY2.87MShares$243 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$160 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C31.03MShares$87.6 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$85.5 Million0.04% of portfolio
-
Stephens Investment Management Group LLC697KShares$59.1 Million0.7% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.43B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...